Evidence map›Paper›PMID 39930981›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Single-Cell Transcriptomes of Immune Cells from Multiple Compartments Redefine the Ontology of Myeloid Subtypes Post-Stroke.

Mo Yang, Yixiang Li, Kaibin Shi, Xuezhu Wang, Xiangrong Liu, Xiang Huang, Fu-Dong Shi, Shaojie Ma, Mingfeng Li, Yilong Wang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Unveiling the glymphatic system's role in brain aging: A comprehensive biomarker and modifiable intervention target.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mo YangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.ORCID https://orcid.org/0000-0003-1670-5243
Yixiang LiDepartment of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Kaibin ShiDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Xuezhu WangDepartment of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Xiangrong LiuChina National Clinical Research Center for Neurological Diseases, Beijing, 100070, China.
Xiang HuangInstitute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Fu-Dong ShiDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Shaojie MaInstitute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Mingfeng LiDepartment of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.ORCID https://orcid.org/0000-0002-7959-6008
Yilong WangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.

Funding

Beijing Laboratory of Oral Health PXM2021_014226_000041Beijing Outstanding Young Scientist Program BJJWZYJH01201910025030Beijing Talent Project - Class A: Innovation and Development 2018A12Capital's Funds for Health Improvement and Research 2022-2-2045National Key Research and Development Program of China 2017YFC1307900National Key Research and Development Program of China 2017YFC1307905National Key Research and Development Program of China 2022YFF1501500National Key Research and Development Program of China 2022YFF1501501National Key Research and Development Program of China 2022YFF1501502National Key Research and Development Program of China 2022YFF1501503National Key Research and Development Program of China 2022YFF1501504National Key Research and Development Program of China 2022YFF1501505National Natural Science Foundation of China 32270715National Natural Science Foundation of China 32470712National Natural Science Foundation of China 81825007National Ten-Thousand Talent Plan Leadership of Scientific and Technological InnovationYouth Beijing Scholar Program 010
6 · The paper itself

Abstract

The activation and infiltration of immune cells are hallmarks of ischemic stroke. However, the precise origins and the molecular alterations of these infiltrating cells post-stroke remain poorly characterized. Here, a murine model of stroke (permanent middle cerebral artery occlusion [p-MCAO]) is utilized to profile single-cell transcriptomes of immune cells in the brain and their potential origins, including the calvarial bone marrow (CBM), femur bone marrow (FBM), and peripheral blood mononuclear cells (PBMCs). This analysis reveals transcriptomically distinct populations of cerebral myeloid cells and brain-resident immune cells after stroke. These include a novel CD14

Indexed as

Myeloid CellsStrokeTranscriptomeAnimalsDisease Models, AnimalLeukocytes, MononuclearMacrophagesMaleMiceMice, Inbred C57BLMicrogliaNeutrophilsSingle-Cell Analysisbrainimmune cellsscRNA‐seqskull bone marrowstroke

Identifiers

PMID39930981
PMCPMC11967789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.